US Stock MarketDetailed Quotes
ABIO ARCA biopharma
- 2.400
- 0.0000.00%
Trading Aug 30 16:00 ET
34.82MMarket Cap-4897P/E (TTM)
0.000High0.000Low0Volume0.000Open2.400Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)14.51MShares33.00052wk High1.07P/B11.49MFloat Cap10.06852wk Low--Dividend TTM4.79MShs Float40837854.871Historical High--Div YieldTTM0.00%Amplitude10.068Historical Low--Avg Price1Lot Size
ARCA biopharma Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Current assets | ||||||||||
| Cash, cash equivalents and short term investments | -17.12%33.28M | -12.11%35.9M | -11.81%37.43M | -11.81%37.43M | -12.41%38.49M | -13.53%40.16M | -16.73%40.85M | -20.45%42.45M | -20.45%42.45M | -24.65%43.94M |
| -Cash and cash equivalents | -17.12%33.28M | -12.11%35.9M | -11.81%37.43M | -11.81%37.43M | -12.41%38.49M | -13.53%40.16M | -16.73%40.85M | -20.45%42.45M | -20.45%42.45M | -24.65%43.94M |
| Other current assets | -10.35%537K | -9.98%767K | -36.61%161K | -36.61%161K | -33.72%405K | -50.82%599K | -42.43%852K | -76.08%254K | -76.08%254K | -54.84%611K |
| Total current assets | -17.02%33.82M | -12.07%36.67M | -11.96%37.59M | -11.96%37.59M | -12.70%38.89M | -14.48%40.76M | -17.49%41.7M | -21.54%42.7M | -21.54%42.7M | -25.33%44.55M |
| Non current assets | ||||||||||
| Net PPE | -96.13%12K | -92.92%24K | -30.16%257K | -30.16%257K | -29.47%280K | -27.57%310K | -25.82%339K | -24.12%368K | -24.12%368K | -21.85%397K |
| -Gross PPE | -55.94%230K | -56.31%239K | -18.01%469K | -18.01%469K | -17.06%496K | -17.41%522K | -16.49%547K | -15.88%572K | -15.88%572K | -17.52%598K |
| -Accumulated depreciation | -2.83%-218K | -3.37%-215K | -3.92%-212K | -3.92%-212K | -7.46%-216K | -3.92%-212K | -5.05%-208K | -4.62%-204K | -4.62%-204K | 7.37%-201K |
| Other non current assets | -33.33%12K | -33.33%12K | -33.33%12K | -33.33%12K | -33.33%12K | 0.00%18K | 0.00%18K | 0.00%18K | 0.00%18K | 0.00%18K |
| Total non current assets | -92.68%24K | -89.92%36K | -30.31%269K | -30.31%269K | -29.64%292K | -26.46%328K | -24.84%357K | -23.26%386K | -23.26%386K | -21.10%415K |
| Total assets | -17.62%33.84M | -12.73%36.71M | -12.12%37.86M | -12.12%37.86M | -12.86%39.18M | -14.59%41.08M | -17.55%42.06M | -21.56%43.09M | -21.56%43.09M | -25.30%44.97M |
| Liabilities | ||||||||||
| Current liabilities | ||||||||||
| Payables | 136.93%571K | 44.54%529K | 8.38%362K | 8.38%362K | -45.70%322K | -78.29%241K | -63.91%366K | -70.10%334K | -70.10%334K | -47.57%593K |
| -accounts payable | 136.93%571K | 44.54%529K | 8.38%362K | 8.38%362K | -45.70%322K | -78.29%241K | -63.91%366K | -70.10%334K | -70.10%334K | -47.57%593K |
| Current accrued expenses | -49.53%591K | 45.56%968K | -72.00%175K | -72.00%175K | -42.43%582K | -14.84%1.17M | -56.73%665K | -57.07%625K | -57.07%625K | -46.93%1.01M |
| Current liabilities | -20.66%1.27M | 24.88%1.58M | -43.73%637K | -43.73%637K | -48.79%992K | -42.97%1.6M | -53.44%1.27M | -67.64%1.13M | -67.64%1.13M | -39.13%1.94M |
| Non current liabilities | ||||||||||
| Long term debt and capital lease obligation | --0 | --0 | -27.14%204K | -27.14%204K | -25.58%224K | -26.14%243K | -26.61%262K | -26.89%280K | -26.89%280K | -26.59%301K |
| -Long term capital lease obligation | --0 | --0 | -27.14%204K | -27.14%204K | -25.58%224K | -26.14%243K | -26.61%262K | -26.89%280K | -26.89%280K | -26.59%301K |
| Total non current liabilities | --0 | --0 | -27.14%204K | -27.14%204K | -25.58%224K | -26.14%243K | -26.61%262K | -26.89%280K | -26.89%280K | -26.59%301K |
| Total liabilities | -31.11%1.27M | 3.47%1.58M | -40.44%841K | -40.44%841K | -45.67%1.22M | -41.20%1.85M | -50.33%1.53M | -63.62%1.41M | -63.62%1.41M | -37.69%2.24M |
| Shareholders'equity | ||||||||||
| Share capital | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K |
| -common stock | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K | 0.00%14K |
| -Preferred stock | ---- | ---- | --0 | --0 | ---- | ---- | ---- | --0 | --0 | ---- |
| Retained earnings | -3.87%-193.43M | -3.25%-190.75M | -2.91%-188.74M | -2.91%-188.74M | -2.98%-187.65M | -3.52%-186.23M | -4.53%-184.75M | -5.72%-183.4M | -5.72%-183.4M | -8.60%-182.23M |
| Paid-in capital | 0.24%225.99M | 0.26%225.86M | 0.30%225.75M | 0.30%225.75M | 0.30%225.61M | 0.27%225.45M | 0.26%225.27M | 0.25%225.06M | 0.25%225.06M | 0.25%224.94M |
| Total stockholders'equity | -16.99%32.57M | -13.34%35.13M | -11.17%37.02M | -11.17%37.02M | -11.14%37.97M | -12.73%39.24M | -15.45%40.53M | -18.36%41.67M | -18.36%41.67M | -24.51%42.73M |
| Total equity | -16.99%32.57M | -13.34%35.13M | -11.17%37.02M | -11.17%37.02M | -11.14%37.97M | -12.73%39.24M | -15.45%40.53M | -18.36%41.67M | -18.36%41.67M | -24.51%42.73M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg